Forest Laboratories: Difference between revisions

Latest revision as of 16:26, 16 February 2025

Forest Laboratories[edit]

Logo of Forest Laboratories

Forest Laboratories was an American pharmaceutical company that developed, manufactured, and sold both branded and generic forms of ethical drug products. The company was known for its focus on the development of central nervous system, cardiovascular, and respiratory drugs.

History[edit]

Forest Laboratories was founded in 1956 and was headquartered in New York City. Over the years, the company grew through a combination of internal development and strategic acquisitions. It became well-known for its successful marketing of antidepressants and other central nervous system drugs.

In 2014, Forest Laboratories was acquired by Actavis, a global pharmaceutical company, in a deal valued at approximately $25 billion. This acquisition was part of a trend of consolidation in the pharmaceutical industry, allowing Actavis to expand its product portfolio and global reach.

Products[edit]

Forest Laboratories developed and marketed a variety of pharmaceutical products. Some of the most notable drugs included:

Lexapro (escitalopram) - An antidepressant used to treat major depressive disorder and generalized anxiety disorder.
Namenda (memantine) - A medication used to treat moderate to severe Alzheimer's disease.
Bystolic (nebivolol) - A beta blocker used to treat hypertension.

Research and Development[edit]

Forest Laboratories invested heavily in research and development to bring new drugs to market. The company collaborated with various research institutions and other pharmaceutical companies to develop innovative treatments. Its R&D efforts were primarily focused on the central nervous system, cardiovascular, and respiratory therapeutic areas.

Acquisition by Actavis[edit]

In 2014, Forest Laboratories was acquired by Actavis, which later became known as Allergan. This acquisition allowed Actavis to enhance its specialty brand business and expand its product offerings in the central nervous system and women's health areas.

Related Pages[edit]

Template:Defunct companies of the United States

@@ Line 1: / Line 1: @@
-'''Forest Laboratories''' was a prominent [[pharmaceutical company]] based in [[New York City]], United States. It was known for developing, manufacturing, and selling a wide range of [[prescription drugs]] in various therapeutic areas, including [[central nervous system]] disorders, [[cardiovascular disease]], and [[gastrointestinal]] conditions. Forest Laboratories played a significant role in the pharmaceutical industry before it was acquired by [[Actavis]] (now known as [[Allergan]]) in 2014.
+== Forest Laboratories ==
-==History==
+[[File:Forest_Laboratories_logo.svg|thumb|right|Logo of Forest Laboratories]]
-Forest Laboratories was founded in 1956 by Howard Solomon, who later became its CEO. The company initially started as a small laboratory but grew over the decades into a significant player in the pharmaceutical industry. One of the key strategies for its growth was the licensing of drugs from smaller companies and overseas manufacturers, which allowed Forest to bring a diverse portfolio of medications to the U.S. market.
-In the 1990s and early 2000s, Forest Laboratories experienced significant growth, partly due to the success of its antidepressant drugs, [[Celexa]] (citalopram) and [[Lexapro]] (escitalopram), which became widely prescribed in the United States. These drugs were instrumental in establishing Forest Laboratories as a leading company in the field of psychiatric medication.
+'''Forest Laboratories''' was an American pharmaceutical company that developed, manufactured, and sold both branded and generic forms of ethical drug products. The company was known for its focus on the development of central nervous system, cardiovascular, and respiratory drugs.
-==Acquisition by Actavis==
+== History ==
-In July 2014, Forest Laboratories was acquired by Actavis for about $25 billion. The acquisition was part of a series of mergers and acquisitions in the pharmaceutical industry, aimed at expanding product portfolios and creating more globally competitive companies. Following the acquisition, Forest Laboratories' operations were integrated into Actavis, significantly expanding Actavis' presence in the branded pharmaceutical market. Actavis later changed its name to Allergan, further solidifying its position as a global pharmaceutical giant.
-==Products==
+Forest Laboratories was founded in 1956 and was headquartered in [[New York City]]. Over the years, the company grew through a combination of internal development and strategic acquisitions. It became well-known for its successful marketing of [[antidepressant]]s and other central nervous system drugs.
-Forest Laboratories developed and marketed a wide range of pharmaceutical products, including:
-* [[Celexa]] (citalopram) – An antidepressant medication used to treat major depressive disorder.
+In 2014, Forest Laboratories was acquired by [[Actavis]], a global pharmaceutical company, in a deal valued at approximately $25 billion. This acquisition was part of a trend of consolidation in the pharmaceutical industry, allowing Actavis to expand its product portfolio and global reach.
-* [[Lexapro]] (escitalopram) – Another antidepressant, closely related to Celexa, used for the treatment of major depressive disorder and generalized anxiety disorder.
-* [[Namenda]] (memantine) – A medication used in the treatment of moderate to severe Alzheimer's disease.
-* [[Bystolic]] (nebivolol) – A beta blocker used in the treatment of hypertension (high blood pressure).
-* [[Linzess]] (linaclotide) – A drug used to treat irritable bowel syndrome with constipation and chronic idiopathic constipation.
-==Controversies==
+== Products ==
-Like many pharmaceutical companies, Forest Laboratories faced its share of controversies, particularly related to its marketing practices. The company was criticized and faced legal challenges for off-label promotion of its drugs, as well as its handling of clinical trial data. Despite these challenges, Forest Laboratories maintained a strong presence in the pharmaceutical market until its acquisition by Actavis.
-==Legacy==
+Forest Laboratories developed and marketed a variety of pharmaceutical products. Some of the most notable drugs included:
-The acquisition of Forest Laboratories by Actavis marked the end of an era for one of the pharmaceutical industry's well-known companies. However, the legacy of Forest Laboratories lives on through its products, which continue to benefit patients around the world. The merger also reflects the dynamic nature of the pharmaceutical industry, where consolidation can lead to greater innovation and access to medications for patients globally.
+* '''[[Lexapro]]''' (escitalopram) - An [[antidepressant]] used to treat major depressive disorder and generalized anxiety disorder.
+* '''[[Namenda]]''' (memantine) - A medication used to treat moderate to severe [[Alzheimer's disease]].
+* '''[[Bystolic]]''' (nebivolol) - A [[beta blocker]] used to treat [[hypertension]].
+== Research and Development ==
+Forest Laboratories invested heavily in [[research and development]] to bring new drugs to market. The company collaborated with various research institutions and other pharmaceutical companies to develop innovative treatments. Its R&D efforts were primarily focused on the central nervous system, cardiovascular, and respiratory therapeutic areas.
+== Acquisition by Actavis ==
+In 2014, Forest Laboratories was acquired by Actavis, which later became known as [[Allergan]]. This acquisition allowed Actavis to enhance its specialty brand business and expand its product offerings in the central nervous system and women's health areas.
+== Related Pages ==
+* [[Actavis]]
+* [[Allergan]]
+* [[Pharmaceutical industry]]
+* [[Antidepressant]]
+* [[Alzheimer's disease]]
+{{Pharmaceutical companies of the United States}}
+{{Defunct companies of the United States}}
 [[Category:Pharmaceutical companies of the United States]]
+[[Category:Defunct companies of the United States]]
 [[Category:Companies based in New York City]]
-[[Category:2014 mergers and acquisitions]]
+[[Category:Companies established in 1956]]
+[[Category:Companies disestablished in 2014]]
-{{pharma-stub}}